Prophylaxis with direct-acting antivirals for kidney transplantation from hepatitis C virus-infected donors to uninfected recipients: a randomized controlled trial ("PREVENT HCV")
University of Wisconsin was apart of a larger study through Johns Hopkins University to compare utilization of antiviral prophylaxis HCV donor positive and recipient negative kidney transplantation versus standard of care approach currently utilized, transmit-and-treat approach. Then to compare certain clinical, immunological, inflammatory and virologic complications or outcomes between the two groups
This project is supported by the National Institute of Allergy and Infectious Diseases Grant U01AI157931-03.
